Researcher.Life Logo

Farmakoekonomika : Impact Factor & More

eISSN: 2070-4933pISSN: 2070-4909
JournalOpen Access

Key Metrics

CiteScore
1
SNIP
0.28
Recommended pre-submission checks
Powered by Paperpal by Editage

Farmakoekonomika Journal Specifications

Overview
Publisher IRBIS LLC
Language Russian
Article Processing ChargesRUB 15000
Publication Time8
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicyCopyright Notice
License typeCC BY-NC-SA
OA statementVisit website
View less

Planning to publish in Farmakoekonomika ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Farmakoekonomika

Chemoreactomic analysis of magnesium- and vitamin B6-depleting drugs within the Anatomical Therapeutic Chemical classification as a basis for preventing adverse effects of pharmacotherapy
  • 27 Apr 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Pharmacoeconomic evaluation of contemporary treatment, prevention, and screening strategies for melanoma: a review of evidence and implications for the Russian healthcare system
  • 3 Mar 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
A method for evaluating diagnostic effectiveness using algorithms based on opinion obtained from artificial intelligence models
  • 12 Feb 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Features of population consumption of combined glucose-lowering drugs in pharmacy organizations of the Russian Federation
  • 11 Feb 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Studying the risks of drug provision for breast cancer patients in the public procurement system of Russia
  • 9 Feb 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Clinical and economic assessment of an extended release lanreotide formulation (Somatuline® Autogel®) in patients with gastrointestinal neuroendocrine tumors
  • 22 Jan 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Chemoreactomic analysis of magnesium- and vitamin B6-depleting drugs within the Anatomical Therapeutic Chemical classification as a basis for preventing adverse effects of pharmacotherapy
  • 27 Apr 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Pharmacoeconomic evaluation of contemporary treatment, prevention, and screening strategies for melanoma: a review of evidence and implications for the Russian healthcare system
  • 3 Mar 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
A method for evaluating diagnostic effectiveness using algorithms based on opinion obtained from artificial intelligence models
  • 12 Feb 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Features of population consumption of combined glucose-lowering drugs in pharmacy organizations of the Russian Federation
  • 11 Feb 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Studying the risks of drug provision for breast cancer patients in the public procurement system of Russia
  • 9 Feb 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Clinical and economic assessment of an extended release lanreotide formulation (Somatuline® Autogel®) in patients with gastrointestinal neuroendocrine tumors
  • 22 Jan 2026
  • FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

FAQs on Farmakoekonomika